ELI LILLY AND COMPANY Deferred Employee Stock Ownership Plan, Issuance of Shares or Sale of Treasury Shares
ELI LILLY AND COMPANY (LLY) had Deferred Employee Stock Ownership Plan, Issuance of Shares or Sale of Treasury Shares of $0 as of 2011-12-31, per its 10-K filed 2012-02-24.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:TreasuryStockDeferredEmployeeStockOwnershipPlan · last filed 2012-02-24
- 2011-12-31: Deferred Employee Stock Ownership Plan, Issuance of Shares or Sale of Treasury Shares $0.00.
- 2011-09-30: Deferred Employee Stock Ownership Plan, Issuance of Shares or Sale of Treasury Shares -$14.40M.
- 2011-06-30: Deferred Employee Stock Ownership Plan, Issuance of Shares or Sale of Treasury Shares -$10.70M.
- 2011-03-31: Deferred Employee Stock Ownership Plan, Issuance of Shares or Sale of Treasury Shares -$10.90M.
| Period end | Deferred Employee Stock Ownership Plan, Issuance of Shares or Sale of Treasury Shares |
|---|---|
| 2011-12-31 | $0.00 10-K · filed 2012-02-24 |
| 2011-09-30 | -$14.40M 10-Q · filed 2011-10-28 |
| 2011-06-30 | -$10.70M 10-Q · filed 2011-07-29 |
| 2011-03-31 | -$10.90M 10-Q · filed 2011-04-29 |
| 2010-12-31 | -$52.40M 10-K · filed 2012-02-24 |
| 2010-09-30 | -$58.10M 10-Q · filed 2010-10-29 |
| 2010-06-30 | -$73.30M 10-Q/A · filed 2010-08-02 |
| 2010-03-31 | -$75.30M 10-Q · filed 2010-07-30 |
| 2009-12-31 | -$77.40M 10-K · filed 2011-02-22 |
| 2009-09-30 | -$79.90M 10-Q · filed 2009-10-30 |
| 2009-06-30 | -$82.00M 10-Q · filed 2009-07-31 |
| 2008-12-31 | -$86.30M 10-K · filed 2010-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |